Form 4: Amgen VP, Finance & CAO Matthew C. Busch Reports Stock Disposal

Matthew C. Busch, VP, Finance & CAO of Amgen Inc., reported disposing of 174 shares of common stock on March 17, 2025, to cover tax obligations related to vested restricted stock units.

Summary

• On March 17, 2025, Matthew C. Busch, VP, Finance & CAO of Amgen Inc., disposed of 174 shares of Amgen common stock.
• The transaction was executed at a price of $313.71 per share.
• This disposal was related to covering tax obligations associated with vested restricted stock units (RSUs).
• Following the transaction, Busch directly owns 5,117 shares of Amgen common stock, which includes 111 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a routine transaction. It doesn't indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates a common practice of executives selling shares to cover tax obligations related to vested equity compensation.

Stakeholder Impact

• The disposal of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the small number of shares involved.

Key Dates

Keywords

Form 4, Amgen, Matthew C. Busch, Stock Disposal, Insider Trading, AMGN, VP Finance, CAO, Dividend Equivalents, Restricted Stock Units